Regenxbio lobbies on its own behalf. For Q4 2023 it reported $91K across 1 client report and lists 1 lobbyist across its filings. Issues include Health Issues, Taxation/Internal Revenue Code, Immigration and Trade (domestic/foreign).
| Client | Reported | Issues |
|---|---|---|
| REGENXBIO | $91K | Health Issues, Taxation/Internal Revenue Code, Immigration |
| Year | Reported | Clients |
|---|---|---|
| 2023 | $438K | 1 |
| 2022 | $372K | 1 |
| 2021 | $235K | 1 |
| 2020 | $415K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.